Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynne A Bui

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|April 7, 2015
The preclinical development of biosimilars: introductionLynne A Bui
Seminars in Oncology|February 25, 2014
Developing clinical trials for biosimilarsLynne A Bui, Carrie Taylor
Hearing Research|July 3, 2010
GABAergic organization of the auditory cortex in the mustached bat (Pteronotus p. parnellii)Jeffery A Winer, Lynne A Bui, Jane H Hong, et al.
Drug Discovery Today|April 28, 2015
Key considerations in the preclinical development of biosimilarsLynne A Bui, Susan Hurst, Gregory L Finch, et al.
Leukemia Research|December 31, 2013
Phase I evaluation of XL019, an oral, potent, and selective JAK2 inhibitorSrdan Verstovsek, Constantine S Tam, Martha Wadleigh, et al.
Cancer Chemotherapy and Pharmacology|February 26, 2021
A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancersWen Wee Ma, Mojun Zhu, Elaine T Lam, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|April 7, 2015
The preclinical development of biosimilars: introductionLynne A Bui
Seminars in Oncology|February 25, 2014
Developing clinical trials for biosimilarsLynne A Bui, Carrie Taylor
Hearing Research|July 3, 2010
GABAergic organization of the auditory cortex in the mustached bat (Pteronotus p. parnellii)Jeffery A Winer, Lynne A Bui, Jane H Hong, et al.
Drug Discovery Today|April 28, 2015
Key considerations in the preclinical development of biosimilarsLynne A Bui, Susan Hurst, Gregory L Finch, et al.
Leukemia Research|December 31, 2013
Phase I evaluation of XL019, an oral, potent, and selective JAK2 inhibitorSrdan Verstovsek, Constantine S Tam, Martha Wadleigh, et al.
Cancer Chemotherapy and Pharmacology|February 26, 2021
A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancersWen Wee Ma, Mojun Zhu, Elaine T Lam, et al.
Pageof 1